The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets ...

Georgia has moved to renew contracts with Israeli technology firm Cellebrite DI Ltd for software used to extract data from ...

Meeting to be held in Chicago on March 5 and in Denver on March 6 hosted by Craig-Hallum. Discover the Best Stocks and Maximize Your Portfolio: ...

Meeting to be held in Toronto, Canada on March 4 hosted by Needham.Discover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) has received an average recommendation of “Buy” from the eight research ...

Cellebrite DI Ltd. (CLBT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in ...

Detailed price information for Cellebrite Di Ltd (CLBT-Q) from The Globe and Mail including charting and trades.

Cellebrite DI Ltd (CLBT) reports robust financial performance with a 25% increase in ARR and outlines future growth strategies amid ongoing CEO search.

Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) fell 7.2% on Thursday following a weaker than expected earnings announcement. The company traded as low as $21.80 and last traded at $23.13.

Welcome to the Cellebrite Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for ...

Cellebrite DI (CLBT) reported its fourth-quarter and full-year 2024 earnings, revealing a revenue of $109 million for Q4, surpassing expectations with an EPS of $0.08 against a forecast of $0.06. The ...